Patents

#1

Patent on platform technology applied to 5-FU prodrug granted in US860399B2 (2013), EP2393472B1(2019), expiration date: 19/03/2030

#2

PCT patent filed on Gemcitabine amphiphile prodrug, PCT/AU2019/050363

#3

PCT patent filed on Platinum-based amphiphile prodrug, PCT/AU2019/050646

NanoMed logo

© 2021 NanoMed Pty Ltd

Designed by Ilanah ©

CONTACT

Lane Cove West Business Park
Unit 2, 11/13 Orion Road,
Lane Cove West NSW 2066,
Australia

Telephone: +61 2 9418 6050
E-mail: info@nanomed.com.au

Close Menu